Cargando…
Use of Dalfampridine in a Young Child with Episodic Ataxia Type 2
Episodic ataxia type 2 (EA2) is a rare autosomal dominant disorder associated with mutations of the CACNA1A gene.( 1 ) Because there is no curative therapy available, EA2 is typically managed symptomatically. First line treatment has typically been with acetazolamide.( 2 ) Dalfampridine has also bee...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811424/ https://www.ncbi.nlm.nih.gov/pubmed/35127965 http://dx.doi.org/10.1177/2329048X221075447 |